Sereneuro Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 6

Sereneuro Therapeutics General Information

Description

Operator of a biotechnology company intended to decipher the functional heterogeneity of human pain perception and develop non-opioid therapies for pain relief. The company offers advanced therapy development focused on non-addictive treatments, enabling healthcare providers, researchers, and patients to access safer pain management with reduced risk of dependency.

Contact Information

Website
www.sereneuro.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD 21205
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Services
Vertical(s)
Life Sciences
Corporate Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD 21205
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sereneuro Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 05-Oct-2026 Completed Pre-Clinical Trials
5. Accelerator/Incubator 14-May-2025 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2025 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Dec-2024 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
To view Sereneuro Therapeutics’s complete valuation and funding history, request access »

Sereneuro Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sereneuro Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ecphora Capital Venture Capital Minority
Nucleate Accelerator/Incubator
University of Toronto University
Johns Hopkins Technology Ventures Accelerator/Incubator
Creative Destruction Lab Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Sereneuro Therapeutics FAQs

  • When was Sereneuro Therapeutics founded?

    Sereneuro Therapeutics was founded in 2024.

  • Where is Sereneuro Therapeutics headquartered?

    Sereneuro Therapeutics is headquartered in Baltimore, MD.

  • What is the size of Sereneuro Therapeutics?

    Sereneuro Therapeutics has 8 total employees.

  • What industry is Sereneuro Therapeutics in?

    Sereneuro Therapeutics’s primary industry is Drug Discovery.

  • Is Sereneuro Therapeutics a private or public company?

    Sereneuro Therapeutics is a Private company.

  • What is Sereneuro Therapeutics’s current revenue?

    The current revenue for Sereneuro Therapeutics is .

  • Who are Sereneuro Therapeutics’s investors?

    Ecphora Capital, Nucleate, University of Toronto, Johns Hopkins Technology Ventures, and Creative Destruction Lab are 5 of 6 investors who have invested in Sereneuro Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process